Cancer research
A groundbreaking new study published in Blood Advances has made significant strides in gene therapy, particularly in the treatment of monogenetic disorders such as hemoglobinopathies and lysosomal storage diseases. A team of researchers from the Fred Hutchinson Cancer Research Center has developed a novel strategy to maintain engraftment levels in
Cancer
Researchers from the Institute of Nano Science and Technology have made a significant breakthrough in cancer gene therapy by developing a novel nanomaterial that can target and treat glioma, a type of brain cancer, with unprecedented efficiency. The innovative approach involves the use of exfoliated 2D transition-metal dichalcogenide (TMDCs)-based
Cancer research
Researchers at the University of Melbourne have identified new insights into the genetic and environmental factors contributing to colon cancer. Specifically, they have found that non-genetic factors such as environmental risk factors, prior oncologic treatments, and bacterial genotoxins colonizing the intestine, particularly colibactin-producing Escherichia coli, play a significant role in
Cancer
Researchers at Hokkaido University in Japan have investigated the relationship between mitochondrial DNA copy numbers (mtDNA-CN) and gastric cancer progression. The study involved analyzing DNA samples extracted from gastric cancer tissues of 182 patients. The results showed that mtDNA-CN was significantly associated with tumor stage, indicating its potential utility as
Cancer
Research conducted at the University of Michigan has investigated the use of the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) and Problem List (PL) in assessing distress in individuals presenting to a cancer genetics clinic. The study aimed to evaluate the utility of these tools in an unselected population
Cancer research
Research has identified the key role of ZMAT3 and CDKN1A in regulating tumor suppression through the p53 gene. By studying the p53-induced gene program, scientists have shed light on the universal effectors of tumor suppression. Tuba-seqUltra somatic genome editing and tumor barcoding in a mouse lung adenocarcinoma model, combinatorial in
Cancer research
Research from Huazhong University of Science and Technology has shed new light on the specific impact of mitophagy on microsatellite instability-high (MSI-H) colorectal cancer (CRC). The study, published in Molecular Medicine, identified USP14 as a key regulator of mitophagy in MSI-H CRC, highlighting the USP14/BAG4/PRKN axis as a
Cancer research
A new research study conducted by scientists at the First Affiliated Hospital of Nanjing Medical University in China has made a significant breakthrough in detecting pancreatic cancer at an early stage. The study used a novel approach called cell-free DNA (cfDNA) fragmentomics, which integrates advanced machine learning algorithms to identify
Cancer research
Researchers have identified two new biomarkers that can predict therapeutic outcomes for patients with relapsed and refractory multiple myeloma (RRMM) undergoing CAR-T therapy. The study, led by the H. Lee Moffitt Cancer Center and Research Institute, found that high levels of serum soluble B-cell maturation antigen (sBCMA) and high metabolic
Cancer
Research into DNA nanostructures has shown promise in the development of cancer gene therapy, allowing for precise manipulation of matter at the nanoscale. Engineered DNA nanostructures can target specific organelles within cells, enabling new therapeutic strategies for treatment of cancer. The potential for rational control of targeted organelles holds significant
Cancer
Researchers at Universidad Autonoma de Madrid have made significant progress in understanding the interactions between doxorubicin, a widely used cancer treatment, and lipid components of liposomes for its delivery. The study combines electrochemical measurements, attenuated total reflection spectroscopy, and molecular dynamics simulations to characterize the interactions between doxorubicin and lipid
Cancer
Researchers from Central South University have made a significant breakthrough in cancer treatment by developing a degradable metal-small molecule drug coordination nanomedicine that enhances chemodynamic therapy (CDT) effects for lung cancer treatment. This innovative approach targets the DNA damage repair system, providing a new avenue for cancer treatment. Funded by
